Minerva ginecologica | 12 Dec 2020
S Milliken, J May, PA Sanderson, MA Congiu, O D'Oria, T Golia D'Augè, G Caruso, V Di Donato, P Benedetti Panici and A Giannini
Vulvar cancer accounts for ~4% of all gynaecological malignancies and the majority of tumours (>90%) are squamous cell (keratanising, ~60% and warty/basaloid, ~30%). Surgical excision forms the foundation of treatment, with resection margin status being the single most influential factor when predicting clinical outcome. There has been a paradigm shift concerning surgical approaches and radicality when manging vulvar cancer within recent times, largely owing to a desire to preserve vulvar structure and function without compromising oncological outcome. As such the safety of the size of resection margin has been called into question. In this narrative review we consider the current literature on the safety of resection margins for vulvar cancer.
* Data courtesy of Altmetric.com